The Histological Impact of Amikacin on Renal Tissue of Rats: The Role of Vitamin D3

Section: Research Paper

Abstract

Background: Amikacin is a strong aminoglycoside antibiotic which mainly targets Gram-negative bacteria that are resistant to multiple drugs. Its effectiveness remains restricted because of its potential to cause kidney damage. The primary reason for renal injury after amikacin use is excessive oxidative stress causing damage to tubular epithelial cells through enhancing both mitochondrial dysfunction and inflammatory responses. Vitamin D₃ has an antioxidant and anti-inflammatory properties that help protect against tissue damage.


Objective: The research investigated the renal protective effect of vitamin D₃ after amikacin toxicity through histopathological and morphometric assessments of rat kidney tissue.


Methods: Twenty-four adult albino rats were randomly divided into four groups: control, amikacin (300 mg/kg, i.p.), vitamin D₃ (500 IU/kg, orally) + amikacin (500 IU/kg, i.p.), and vitamin D₃ (500 IU/kg, orally) alone. The treatment spanned two weeks for vitamin D₃ followed by seven days of amikacin.  Hematoxylin and eosin staining was used to study kidney tissues.


Results: The administration of amikacin alone lead to major kidney tissue damage causing both tubular and glomerular injuries with thinning of epithelial cells and enlarged Bowman’s space. The combination of vitamin D₃ with amikacin successfully prevented these lesions, maintained normal glomerular dimensions and protected tubular tissue from damage. The research established a strong negative connection (r=–0.82, p<0.001) between glomerular diameter and necrotic tubules which confirmed the protection of structural elements.


Conclusion: Vitamin D₃ showed effective protection for kidney health when used to treat amikacin-induced kidney damage. The combination of histological and morphometric analyses confirmed kidney protection through vitamin D₃ which demonstrates its protective effects against aminoglycoside toxicity in kidneys.

References

  1. Thy M, Timsit JF, de Montmollin E. Aminoglycosides for the treatment of severe infection due to resistant gram-negative pathogens. Antibiotics. 2023 May 6;12(5):860. doi: https://doi.org/10.3390/antibiotics12050860.
  2. Chen LF, Kaye D. Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides. Infect Dis Clin North Am. 2009; 23(4):1053-75. Available from: https://www.id.theclinics.com/article/S0891-5520(09)00049-X/abstract
  3. Serio AW, Keepers T, Andrews L, Krause KM. Aminoglycoside revival: review of a historically important class of antimicrobials undergoing rejuvenation. EcoSal Plus. 2018 Dec 31;8(1):10-128. Doi: https://doi.org/10.1128/ecosalplus.esp-0002-2018.
  4. Ramirez MS, Tolmasky ME. Amikacin: Uses, Resistance, and Prospects for Inhibition. Molecules 2017, 22(12), 2267; Doi: https://doi.org/10.3390/molecules22122267
  5. Endo A, Hanawa K, Nemoto A, Ishikawa T, Kazama S, Kagami Y, et al. Evaluation of nephrotoxicity and ototoxicity following amikacin administration once daily or every 48 hours in neonates. Medicine. 2022 Oct 28;101(43):e31425. Doi: https://doi.org/10.1097/MD.0000000000031425.
  6. Dobrek L. A Synopsis of Current Theories on Drug-Induced Nephrotoxicity. Life. 2023; 13(2):325. Doi: https://doi.org/10.3390/life13020325.
  7. Karimzadeh I, Abdollahpour-Alitappeh M, Ghaffari S, Mahi-Birjand M, Barkhordari A, Alemzadeh E. Aminoglycosides: Single- or Multiple-daily Dosing? An Updated Qualitative Systematic Review of Randomized Trials on Toxicity and Efficacy. Curr Mol Med. 2024;24(11):1358-1373. Doi: https://doi.org/10.2174/1566524023666230801160452
  8. Saeed ZM, Khattab MI, Khorshid NE, Salem AE. Ellagic acid and cilostazol ameliorate amikacin-induced nephrotoxicity in rats by downregulating oxidative stress, inflammation, and apoptosis. PLoS One. 2022;17(7):e0271591. doi: https://doi.org/10.1371/journal.pone.0271591.
  9. Nagai J, Takano M. Entry of aminoglycosides into renal tubular epithelial cells via endocytosis-dependent and endocytosis-independent pathways. Biochemical pharmacology. 2014 Aug 15;90(4):331-7. doi: https://doi.org/10.1016/j.bcp.2014.05.018.
  10. Moustafa N, El-latif MB, Farid A. Amikacin toxicity revisited: pentoxifylline offers protection in high-risk treatment scenarios. AMB Express. 2025 Oct 22;15(1):153. Doi: https://doi.org/10.1186/s13568-025-01949-8.
  11. Mally A, Jarzina S. Mapping Adverse Outcome Pathways for Kidney Injury as a Basis for the Development of Mechanism-Based Animal-Sparing Approaches to Assessment of Nephrotoxicity. Front Toxicol. 2022 15;4:863643. Doi: https://doi.org/10.3389/ftox.2022.863643.
  12. Sasaki T, Tsuboi N, Haruhara K, Okabayashi Y, Kanzaki G, Koike K, et al. Bowman Capsule Volume and Related Factors in Adults With Normal Renal Function. Kidney Int Rep. 2017 Oct 24;3(2):314-320. Doi: https://doi.org/10.1016/j.ekir.2017.10.007.
  13. Denic A, Gaddam M, Moustafa A, Mullan AF, Luehrs AC, Sharma V, et al. Tubular and Glomerular Size by Cortex Depth as Predictor of Progressive CKD after Radical Nephrectomy for Tumor. J Am Soc Nephrol. 2023 Sep 1;34(9):1535-1545. Doi: https://doi.org/10.1681/ASN.0000000000000180.
  14. Selim A, Khalaf MM, Gad AM, Abd El-Raouf OM. Evaluation of the possible nephroprotective effects of vitamin E and rosuvastatin in amikacin-induced renal injury in rats. J Biochem Mol Toxicol. 2017;31(11). doi: https://doi.org/10.1002/jbt.21957.
  15. Al Sammak M, Ahmed RM, Alazzo N. The Role of Vitamin C in Amelioration of Hepatorenal Toxicity of Cefotaxime in Adult Albino Rats (Histological Study). Open Access Maced J Med Sci. 2021; 9(A):845-848. Doi: https://doi.org/10.3889/oamjms.2021.7116
  16. Azırak S. Prevention of nephrotoxicity induced by amikacin: The role of misoprostol, A prostaglandin E1 analogue. Prostaglandins Other Lipid Mediat. 2022;164:106682. Doi: https://doi.org/10.1016/j.prostaglandins.2022.106682
  17. Rajab BS, Albukhari TA, Khan AA, Refaat B, Almehmadi SJ, Nasreldin N, et al. Antioxidative and Anti-Inflammatory Protective Effects of β-Caryophyllene against Amikacin-Induced Nephrotoxicity in Rat by Regulating the Nrf2/AMPK/AKT and NF-κB/TGF-β/KIM-1 Molecular Pathways. Oxid Med Cell Longev. 2022; 2022:4212331. doi: https://doi.org/10.1155/2022/4212331.
  18. Oliveira BM, de Almeida LF, Deluque AL, Souza CS, Maciel ALD, Francescato HDC, Costa RS, Giovanini C, de Paula FJA, Coimbra TM. Calcitriol Reduces the Inflammation, Endothelial Damage and Oxidative Stress in AKI Caused by Cisplatin. International Journal of Molecular Sciences. 2022; 23(24):15877. Doi: https://doi.org/10.3390/ijms232415877
  19. Chen H, Zhang H, Li AM, Liu YT, Liu Y, Zhang W, Yang C, Song N, Zhan M, Yang S. VDR regulates mitochondrial function as a protective mechanism against renal tubular cell injury in diabetic rats. Redox Biol. 2024 Apr;70:103062. Doi: https://doi.org/10.1016/j.redox.2024.103062.
  20. Malekmakan L, Karimi Z, Mansourian A, Pakfetrat M, Roozbeh J, Rahimi Jaberi K. Role of vitamin D in oxidative stress modulation in end-stage renal disease patients: A double-blind randomized clinical trial. Hemodial Int. 2020 Jul;24(3):367-373. Doi: https://doi.org/10.1111/hdi.12849.
  21. Zhong W, Gu B, Gu Y, Groome LJ, Sun J, Wang Y. Activation of vitamin D receptor promotes VEGF and CuZn-SOD expression in endothelial cells. The Journal of steroid biochemistry and molecular biology. 2014 Mar 1;140:56-62. Doi: https://doi.org/10.1016/j.jsbmb.2013.11.017
  22. Demir F, Demir M, Aygun H. Evaluation of the protective effect of paricalcitol and vitamin D3 at doxorubicin nephrotoxicity in rats with 99mTechnetium-dimercaptosuccinic acid renal scintigraphy and biochemical methods. Hum Exp Toxicol. 2021 Feb;40(2):274-283. Doi: https://doi.org/10.1177/0960327120950010
  23. Cirilo MAS, Ribeiro FPB, Lima NKDS, Silva JK, Gomes JADS, Albuquerque JSS, et al. Paricalcitol prevents renal tubular injury induced by ischemia-reperfusion: Role of oxidative stress, inflammation and AT1R. Mol Cell Endocrinol. 2024 Dec 1;594:112349. Doi: https://doi.org/10.1016/j.mce.2024.112349
  24. Abdelghany HA, Refaat B, Hassan AA. The protective effects of Vitamin D against Cadmium-induced nephrotoxicity. Journal of Trace Elements and Minerals.2023;6(1). Doi: https://doi.org/10.1016/j.jtemin.2023.100097.
  25. Aksoz E, Metin FS, Guclu N, Celebi M, Coskun SK, Korkut O. Vitamin D Protects Against Gentamicin-Induced Kidney Damage in Rats Through Its Antioxidant and Anti-Inflammatory Effects. J Appl Toxicol. 2025;45(12):2613-2623. Doi: https://doi.org/10.1002/jat.4862
  26. Al-Sroji RY, Al-Laham S and Almandili A. Protective effects of vitamin D3 (cholecalciferol) on vancomycin-induced oxidative nephrotoxic damage in rats. PHARMACEUTICAL BIOLOGY .2023, 61(1);755–66. Doi: https://doi.org/10.1080/13880209.2023.2204916
  27. Wang H, Yu X, Liu D, Qiao Y, Huo J, Pan S, et al. VDR Activation Attenuates Renal Tubular Epithelial Cell Ferroptosis by Regulating Nrf2/HO-1 Signaling Pathway in Diabetic Nephropathy. Adv Sci (Weinh). 2024 Mar;11(10):e2305563. doi: https://doi.org/10.1002/advs.202305563
  28. National Research Council. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC: National Academies Press; 2011.
  29. Kim SE, Shin HY, Lee EY, Yoo YJ, Kim RH, Cho JH, et al. Effect of therapeutic hypothermia against renal injury in a rat model of asphyxial cardiac arrest: A focus on the survival rate, pathophysiology and antioxidant enzymes. Mol Med Rep. 2022;25:19. Doi: https://doi:10.3892/mmr.2021.12535.
  30. Farris AB, Colvin RB. Renal interstitial fibrosis: mechanisms and evaluation. Current Opinion in Nephrology and Hypertension. 2012;21(3):289–300. Doi: https://doi.org/10.1097/mnh.0b013e3283521cfa
  31. Vicente-Vicente L, Casanova AG, Hernández-Sánchez MT, Pescador M, López-Hernández FJ, Morales AI. A systematic meta-analysis on the efficacy of pre-clinically tested nephroprotectants at preventing aminoglycoside nephrotoxicity. Toxicology. 2017; 377:14-24. Doi: https://doi.org/10.1016/j.tox.2016.12.003
  32. Awdishu L, Joy MS. Endocytosis and Nephrotoxicity—It's a RAP!. Kidney360. 2023 May;4(5):572-574. Doi: https://doi.org/10.34067/KID.0000000000000144
  33. Rybak MJ, Ramphal R. Aminoglycosides. In: Brunton LL, Hilal-Dandan R, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 14th ed. New York: McGraw-Hill; 2023. P:1102 1110.
  34. Bulut G, Basbugan Y, Ari E, Erten R, Bektas H, Alp HH, et al. Paricalcitol may improve oxidative DNA damage on experimental amikacin-induced nephrotoxicity model. Ren Fail. 2016 ;38(5):751-8. Doi: https://doi.org/10.3109/0886022X.2016.1158071
  35. Hur E, Garip A, Camyar A, Ilgun S, Ozisik M, Tuna S, et al. The effects of vitamin d on gentamicin-induced acute kidney injury in experimental rat model. Int J Endocrinol. 2013; 2013:313528. Doi: https://doi.org/10.1155/2013/313528
  36. Rashid U, Khan MR. Fagonia olivieri prevented hepatorenal injuries induced with gentamicin in rat. Biomed Pharmacother. 2017 Apr;88:469-479. Doi: https://doi.org/10.1016/j.biopha.2017.01.088
  37. Mohammed M, Aboulhoda B, Mahmoud R. Vitamin D attenuates gentamicin-induced acute renal damage via prevention of oxidative stress and DNA damage. Human & Experimental Toxicology. 2018;38(3):321-335. Doi: https://doi.org/10.1177/0960327118812166
  38. Refaat B, El-Sebaey AM, Khan A, Albukhari TA, Rajab B, Alqurashi S, et al. Renoprotective effects of vitamin D and thymoquinone, alone and in combination, in a rat co-treatment model of gentamicin-induced acute kidney injury. Molecular and Cellular Biochemistry. 2026 May 21:1-5.Doi: https://doi.org/10.1007/s11010-026-05571-5
Download this PDF file

Statistics

How to Cite

1.
The Histological Impact of Amikacin on Renal Tissue of Rats: The Role of Vitamin D3. Ann. coll. Med. Mosul [Internet]. 2026 Jun. 29 [cited 2026 Jul. 18];48(1):59-67. Available from: https://mmed.uomosul.edu.iq/index.php/mmed/article/view/61251

How to Cite

1.
The Histological Impact of Amikacin on Renal Tissue of Rats: The Role of Vitamin D3. Ann. coll. Med. Mosul [Internet]. 2026 Jun. 29 [cited 2026 Jul. 18];48(1):59-67. Available from: https://mmed.uomosul.edu.iq/index.php/mmed/article/view/61251